This company has shut down. Kedalion Therapeutics is no longer operating.
Explore the Startup GraveyardKedalion Therapeutics is a biotechnology company that develops and commercializes transformative topical ophthalmic therapies.
Kedalion Therapeutics's investors include Novartis Venture Fund, Lagunita BioSciences.
Kedalion Therapeutics is headquartered in Menlo Park, United States.
Kedalion Therapeutics is a biotechnology company that develops and commercializes transformative topical ophthalmic therapies.
Kedalion Therapeutics is at the Series B stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Kedalion Therapeutics — Funding & Investors." VCBacked, November 15, 2021, https://www.vcbacked.co/company/kedalion-therapeutics. Accessed September 30, 2026.
VCBacked. (2021). Kedalion Therapeutics — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/kedalion-therapeutics
{{cite web |title=Kedalion Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/kedalion-therapeutics |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated